
AHR Stock Forecast & Price Target
AHR Analyst Ratings
Bulls say
American Healthcare REIT Inc. has demonstrated robust financial performance highlighted by a rental rate growth of 4.1% year-over-year and exceptional same-store NOI growth of 25.3% in its SHOP segment and 21.7% in ISHC. The company has achieved the highest funds from operations (FFO) growth rate within the Healthcare REIT sector, attributed to effective internal and external strategies that align with favorable industry trends. With a strengthened cost of capital since late 2024, AHR is well-positioned for aggressive and accretive capital deployments, further bolstering its long-term organic growth potential.
Bears say
American Healthcare REIT Inc. has demonstrated a decrease in leverage, with net debt to gross asset value (GAV) ratios improving to 28.8% and 31.1% in recent quarters, down from higher figures in the prior year, indicating some progress in financial stability. However, despite a reduction in net debt to annualized EBITDA ratios, concerns over potential negative operating performance of tenants due to economic headwinds or regulatory changes could significantly affect earnings, leading to a projected ~$0.20 per share earnings headwind. Additionally, the company faces acquisition risk amid these uncertainties, which may hinder its investment pace and overall growth prospects.
This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.
AHR Analyst Forecast & Price Prediction
Start investing in AHR
Order type
Buy in
Order amount
Est. shares
0 shares